Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes
Authors:
- Laura CarramolinoLCLaura Carramolino
- Julián Albarrán-JuárezJulián Albarrán-Juárez
- Anton MarkovAMAnton Markov
- Esther Hernández-SanMiguelEHEsther Hernández-SanMiguel
- Diana SharyshDSDiana Sharysh
- Vanessa CumbicusVCVanessa Cumbicus
- Verónica Labrador-CantareroVLVerónica Labrador-Cantarero
- Peter Loof MøllerPMPeter Loof Møller
- Paula NogalesPNPaula Nogales
- Alberto BenguriaABAlberto Benguria
- Ana DopazoADAna Dopazo
- 19 January 2024
- journal article
- research article
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 3 (2) , 203-220
Abstract
Drugs that lower plasma apolipoprotein B (ApoB)-containing lipoproteins are central to treating advanced atherosclerosis and provide partial protection against clinical events. Previous research showed that lowering ApoB-containing lipoproteins stops plaque inflammation, but how these drugs affect the heterogeneous population of plaque cells derived from smooth muscle cells (SMCs) is unknown. SMC-derived cells are the main cellular component of atherosclerotic lesions and the source of structural components that determine the size of plaques and their propensity to rupture and trigger thrombosis, the proximate cause of heart attack and stroke. Using lineage tracing and single-cell techniques to investigate the full SMC-derived cellular compartment in progressing and regressing plaques in mice, here we show that lowering ApoB-containing lipoproteins reduces nuclear factor kappa-light-chain-enhancer of activated B cells signaling in SMC-derived fibromyocytes and chondromyocytes and leads to depletion of these abundant cell types from plaques. These results uncover an important mechanism through which cholesterol-lowering drugs can achieve plaque regression.Keywords
This publication has 60 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Regression of Atherosclerosis Is Characterized by Broad Changes in the Plaque Macrophage TranscriptomePLOS ONE, 2012
- CD109‐mediated degradation of TGF‐β receptors and inhibition of TGF‐β responses involve regulation of SMAD7 and Smurf2 localization and functionJournal of Cellular Biochemistry, 2011
- Comparative Lipidomics Profiling of Human Atherosclerotic PlaquesCirculation: Cardiovascular Genetics, 2011
- Reversal of Hyperlipidemia With a Genetic Switch Favorably Affects the Content and Inflammatory State of Macrophages in Atherosclerotic PlaquesCirculation, 2011
- Myocardin inhibits cellular proliferation by inhibiting NF-κB(p65)-dependent cell cycle progressionProceedings of the National Academy of Sciences, 2008
- Kruppel-like Factor 4 Abrogates Myocardin-induced Activation of Smooth Muscle Gene ExpressionJournal of Biological Chemistry, 2005
- SM22α Modulates Vascular Smooth Muscle Cell Phenotype During AtherogenesisCirculation Research, 2004
- Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expressionNature, 2004
- Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loadingProceedings of the National Academy of Sciences, 2003